HG Diagnostics is a Southern California-based company co-founded by Panacea Ventures to accomplish the following three broad goals.


Strategic venture: to identity and to fund early-stage companies with breakthrough Dx technologies and discoveries that can meet unmet medical needs and enhance the quality of life for many of our patients globally.


Incubate and commercialize innovative and promising IVD technologies and kits.


A base for global market expansion of the products and services of ourselves and that of our business partners.


Day Zero Diagnostics Announces Completion of $16M Financing Round

This latest fnancing brings the total raised by Day Zero Diagnostics to $49M in venture capital funding and over $18M in non-dilutive funding


We have a small but very experienced and dedicated core team and an extensive network of outside experts with experience extending across science, medicine, strategy and commercial operations to help us accomplish our goals.


Kangsheng Global Gene Technology Co., LTD.(stock code: 9960.HK)is a large high-end medical specialty special inspection service in ...
Kangsheng Beitai will lead the multi-feld clinical application of immunization group bank technology, to provide accurate and effcient diag...
The source is equipped with second-generation sequencing platform NovaSeq 6000, NovaSeg X Plus,third- generation sequencing ...

Contact us

Company address : 19200 Von Karmam Ave, 6 fl.Irvine,CA 92612,USA

The company mailbox : contact@hgd-inc.com

Tel: +1 949 3362200